Atlas Trials

Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

Clinical trial NCT03113994 · TERMINATED

Trial details

NCT number
NCT03113994
Sponsor
Dr. B. Catharine. Craven
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Spinal Cord InjuriesOsteoporosisMetabolic Syndrome
Start date
2018-02-26
Primary completion
2022-12-31
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.